Live from the NIH registry
Studies recruiting near Bridgeport right now
Top 25 of 1,460 recruiting studies, sorted by proximity — each links to its official registry page
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Cancer, Period Problem
Phase 2
Interventional 60 participants sought
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Smilow Cancer Hospital Care Center — Trumbull, Connecticut (3.5 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (16.0 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Follicular Lymphoma, Lymphoma
Phase 2
Interventional 152 participants sought
Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Heart Failure
Phase 4
Interventional 20 participants sought
Yale University — New Haven, Connecticut (16.0 mi)
· Sponsor: Yale University
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Healthy Volunteer Study, Healthy Adults
Phase 1
Interventional 139 participants sought
Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut (16.0 mi)
· Sponsor: Pfizer
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
Breast Cancer, Breast Carcinoma
Phase 2
Interventional 140 participants sought
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
Parkinson's Disease and Movement Disorders Center of Boca Raton d/b/a Parkinson's Research Center of America-Long Island — Commack, New York (24.6 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0019) — New Haven, Connecticut (16.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — New Haven, Connecticut (16.0 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study of Multiparametric Ultrasound Imaging Methods
Pancreatic Cancer, Thyroid Nodule
N/A
Interventional 85 participants sought
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
Solid Tumors (Phase 1)
Phase 1
Interventional 180 participants sought
Yale University — New Haven, Connecticut (16.0 mi)
· Sponsor: Adcendo ApS
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Memorial Sloan Kettering Commack — Commack, New York (24.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Waterbury, Connecticut (26.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Coastal Eye Surgeons — Greenwich, Connecticut (25.3 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Sacituzumab Govitecan in People With Mesothelioma
Mesothelioma, Mesotheliomas Pleural
Phase 2
Interventional 33 participants sought
Memorial Sloan Kettering Cancer Center @ Commack — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Stony Brook University Medical Center — Stony Brook, New York (18.6 mi)
· Sponsor: Takeda
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Chase Medical Research LLC — Hamden, Connecticut (21.0 mi)
· Sponsor: Novo Nordisk A/S
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists — Port Jefferson Station, New York (20.0 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
Yale University — New Haven, Connecticut (16.0 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
Yale University School of Medicine - Section of Cardiology — New Haven, Connecticut (16.0 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
BRCA1 Mutation, POLD1 Gene Mutation
N/A
Interventional 1,000 participants sought
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Yale New Haven Children's Hospital — New Haven, Connecticut (16.0 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — New Haven, Connecticut (16.0 mi)
· Sponsor: AstraZeneca